Fulcrum Therapeutics (FULC) Treasury Shares (2019 - 2025)
Historic Treasury Shares for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $69.5 million.
- Fulcrum Therapeutics' Treasury Shares rose 9757775.31% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.5 million, marking a year-over-year increase of 9757775.31%. This contributed to the annual value of $43072.0 for FY2024, which is 4258.37% down from last year.
- Latest data reveals that Fulcrum Therapeutics reported Treasury Shares of $69.5 million as of Q3 2025, which was up 9757775.31% from $70.7 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Treasury Shares registered a high of $70.7 million during Q2 2025, and its lowest value of $21.0 during Q2 2021.
- Its 5-year average for Treasury Shares is $10.1 million, with a median of $77430.0 in 2022.
- In the last 5 years, Fulcrum Therapeutics' Treasury Shares tumbled by 9980.27% in 2021 and then soared by 9757775.31% in 2025.
- Fulcrum Therapeutics' Treasury Shares (Quarter) stood at $536.0 in 2021, then skyrocketed by 14213.06% to $76718.0 in 2022, then dropped by 2.22% to $75017.0 in 2023, then plummeted by 42.58% to $43072.0 in 2024, then skyrocketed by 161225.22% to $69.5 million in 2025.
- Its Treasury Shares was $69.5 million in Q3 2025, compared to $70.7 million in Q2 2025 and $88048.0 in Q1 2025.